Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer

This publication has 16 references indexed in Scilit:

• The pipeline of new anticancer agents for breast cancer treatment in 2003.
  Critical Reviews in Oncology/Hematology, 2003
• Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines
  International Journal of Cancer, 2003
• Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability
  Oncogene, 2002
• Aromatase, Aromatase Inhibitors, and Breast Cancer
  Clinical Journal of Sport Medicine, 2001
• Systemic treatment of metastatic breast cancer
  Hospital Medicine, 2001
• Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer
  Breast Cancer Research and Treatment, 2000
• Microsatellite instability in ductal carcinomain situ of the breast
  The Journal of Pathology, 1998
• Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
  Journal of Biological Chemistry, 1996
• An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.
  Proceedings of the National Academy of Sciences, 1993
• Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage
  Nature, 1993